ReviewMarine drugs2016
Lipid Production from Nannochloropsis.
Review in Marine drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
82 citing papers in PubMed, 368 citations in OpenAlex.
- Assessment of Cell Disruption Methods in an Integrated Multi-Product Biorefinery forMarine drugs · 2026Article
- Potential of marine dinoflagellates Amphidinium carterae and Prorocentrum minimum as fatty acids producers: A comparative transcriptome and fatty acid profiling study.Journal of microbiology (Seoul, Korea) · 2026Article
- The life cycle of fatty acids in oleaginous stramenopiles: from synthesis to maturation and beyond.BMC plant biology · 2026Review
- Marine Algae as Sustainable Platforms for the Green Synthesis of Metal Nanoparticles.ACS omega · 2026Review
- Partial Replacement of Soybean Protein (30%) withFoods (Basel, Switzerland) · 2026Article
- Thylakoids reorganization enables driving photosynthesis under far-red light in the microalga Nannochloropsis gaditana.The New phytologist · 2026Article
- Yield improvement, grain mineral accumulation, and lipidome alteration inFrontiers in plant science · 2026Article
- Exploring the Potential of Microalgae as Feed Ingredients for Sustainable Aquaculture: A Review of Nutritional and Environmental Benefits.Aquaculture nutrition · 2026Review
- Omega-3 Source Matters: Comparative Lipid Signatures and Quantitative Distribution of EPA/DHA Across Marine Resources.Marine drugs · 2025Article
- Transcriptomic Survey of How Acetate Addition Affected the Growth inLife (Basel, Switzerland) · 2025Article
- Article
- Greener Extraction Solutions for Microalgal Compounds.Marine drugs · 2025Review
- Exploration of a cultivation strategy to improve eicosapentaenoic acid (EPA) production and growth of a Korean strain of Nannochloropsis oceanica cultivated under different light sources.Biotechnology for biofuels and bioproducts · 2025Article
- A Push-Pull Strategy to Enhance Biomass and Lipid Production inMicroorganisms · 2025Article
- Review
- Bioremediation of Synthetic Wastewater with Contaminants of Emerging Concern byBioengineering (Basel, Switzerland) · 2025Article
- Target of Rapamycin is a crucial regulator of photosynthesis and nutrient metabolism partitioning in Nannochloropsis gaditana.Biotechnology for biofuels and bioproducts · 2025Article
- Reestablishment of an algae-bacteria pest model using continuous passage in the laboratory.Frontiers in microbiology · 2025Article
- A review of marine microalgae-based lipids production: biosynthesis, technological advancements, and practical applications.Frontiers in nutrition · 2025Review
- Profiles of volatiles in microalgae depend on the extraction and analytical methods.Frontiers in bioengineering and biotechnology · 2025Article
22 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microalgae are sunlight-driven green cell factories for the production of potential bioactive products and biofuels. Nannochloropsis represents a genus of marine microalgae with high photosynthetic efficiency and can convert carbon dioxide to storage lipids mainly in the form of triacylglycerols and to the ω-3 long-chain polyunsaturated fatty acid eicosapentaenoic acid (EPA). Recently, Nannochloropsis has received ever-increasing interests of both research and public communities. This review aims to provide an overview of biology and biotechnological potential of Nannochloropsis, with the emphasis on lipid production. The path forward for the further exploration of Nannochloropsis for lipid production with respect to both challenges and opportunities is also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.